Aart-jan J. Van Der Lely

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Liver Fibrosis as a Predictor of Cardiovascular Risk in Patients with Severe Obesity.

Liver Fibrosis as a Predictor of Cardiovascular Risk in Patients with Severe Obesity.

Journal: Journal of clinical medicine

Published: September 30, 2025

Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo-controlled trial.

Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo-controlled trial.

Journal: Diabetes, obesity & metabolism

Published: July 01, 2025

Prevalence and Determinants of Diabetes Mellitus in 2338 Long-Term Dutch Childhood Cancer Survivors (DCCS-LATER2 Study).

Prevalence and Determinants of Diabetes Mellitus in 2338 Long-Term Dutch Childhood Cancer Survivors (DCCS-LATER2 Study).

Journal: The Journal of clinical endocrinology and metabolism

Published: September 24, 2024

Prevalence and determinants of metabolic syndrome in 2338 childhood cancer survivors: A Dutch Childhood Cancer Survivor LATER 2 study.

Prevalence and determinants of metabolic syndrome in 2338 childhood cancer survivors: A Dutch Childhood Cancer Survivor LATER 2 study.

Journal: Cancer

Published: July 29, 2024

Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study.

Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study.

Journal: European journal of endocrinology

Published: May 23, 2024

Long-term safety of growth hormone replacement therapy in survivors of cancer and tumors of the pituitary region.

Long-term safety of growth hormone replacement therapy in survivors of cancer and tumors of the pituitary region.

Journal: Endocrine-related cancer

Published: March 22, 2023

An Unexpected Effect of Ketone Body and GH Co-Administration.

An Unexpected Effect of Ketone Body and GH Co-Administration.

Journal: The Journal of clinical endocrinology and metabolism

Published: November 18, 2022

Dissecting the In Vitro Efficacy of Octreotide and Cabergoline in GH- and GH/PRL-Secreting Pituitary Tumors.

Dissecting the In Vitro Efficacy of Octreotide and Cabergoline in GH- and GH/PRL-Secreting Pituitary Tumors.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 08, 2022

KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study.

KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study.

Journal: BMJ open

Published: February 16, 2022

Cardiovascular risk profile in growth hormone-treated adults with craniopharyngioma compared to non-functioning pituitary adenoma: a national cohort study.

Cardiovascular risk profile in growth hormone-treated adults with craniopharyngioma compared to non-functioning pituitary adenoma: a national cohort study.

Journal: European journal of endocrinology

Published: May 10, 2021

Soluble Klotho: a possible predictor of quality of life in acromegaly patients.

Soluble Klotho: a possible predictor of quality of life in acromegaly patients.

Journal: Endocrine

Published: January 28, 2020

T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly.

T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly.

Journal: European journal of endocrinology

Published: October 18, 2019

Showing 1-12 of 46

Last Updated: 09/26/2026